Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine versus methadone maintenance treatment in prison
IRCT20170702034844N7Phase 3Completed
- Sponsor
- Faran Shimi
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing Buprenorphine arm with Methadone arm (2 arms). Primary endpoint: Proportion of weekly negative urine test for morphine. Started Sep 2020; status: completed.
02
Drugs
buprenorphinemethadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20170702034844N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170702034844N7.